{"analyses":[{"ciLowerLimit":"1.01","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.57","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.44","paramType":"Odds Ratio (OR)","paramValue":"1.26","statisticalMethod":"Regression, Logistic"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"4","value":"2"},{"groupId":"OG001","lowerLimit":"2","upperLimit":"5","value":"3"}]}],"title":"Death at or before study visit"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"7","upperLimit":"12","value":"9"},{"groupId":"OG001","lowerLimit":"13","upperLimit":"19","value":"16"}]}],"title":"Hospitalized, on invasive mech. vent. or ECMO"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3","upperLimit":"6","value":"4"},{"groupId":"OG001","lowerLimit":"2","upperLimit":"6","value":"4"}]}],"title":"Hospitalized, on non-invasive vent./high flow O2"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"6","upperLimit":"11","value":"8"},{"groupId":"OG001","lowerLimit":"7","upperLimit":"13","value":"10"}]}],"title":"Hospitalized, requiring supplemental oxygen"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4","upperLimit":"8","value":"6"},{"groupId":"OG001","lowerLimit":"2","upperLimit":"5","value":"3"}]}],"title":"Hospitalized, not on O2, requiring ongoing care"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"3","value":"2"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"2","value":"1"}]}],"title":"Hospitalized, not requiring O2, no longer req care"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"30","upperLimit":"39","value":"34"},{"groupId":"OG001","lowerLimit":"28","upperLimit":"36","value":"31"}]}],"title":"Not hospitalized, limit on activities/req home O2"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"30","upperLimit":"39","value":"34"},{"groupId":"OG001","lowerLimit":"28","upperLimit":"36","value":"32"}]}],"title":"Not hospitalized, no limitations on activities"}],"denoms":[{"counts":[{"groupId":"OG000","value":"515"},{"groupId":"OG001","value":"518"}],"units":"Participants"}],"description":"The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 8) Death; 7) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 6) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 5) Hospitalized, requiring supplemental oxygen; 4) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 3) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 1) Not hospitalized, no limitations on activities. Data was imputed using last observation carried forward or worst possible score based on hospitalization status (2 if not hospitalized, 7 if hospitalized) when there was a change in hospitalization status since last score. Deaths were imputed as an 8.","dispersionType":"95% Confidence Interval","groups":[{"description":"200 mg of Remdesivir administered intravenously on Day 1, followed by a 100 mg once-daily maintenance dose of Remdesivir while hospitalized for up to a 10-day total course and 4 mg (2 tablets of 2 mg) of Baricitinib administered orally daily for the duration of the hospitalization up to a 14-day total course.","id":"OG000","title":"Remdesivir Plus Baricitinib"},{"description":"200 mg of Remdesivir administered intravenously on Day 1, followed by a 100 mg once-daily maintenance dose of Remdesivir while hospitalized for up to a 10-day total course and 4 mg (2 tablets of 2 mg) of Baricitinib Placebo administered orally daily for the duration of the hospitalization up to a 14-day total course.","id":"OG001","title":"Remdesivir Plus Placebo"}],"paramType":"NUMBER","populationDescription":"The intent-to-treat (ITT) population includes all participants who were randomized.","reportingStatus":"POSTED","timeFrame":"Day 15","title":"Percentage of Participants at Each Clinical Status Using Ordinal Scale at Day 15","type":"SECONDARY","unitOfMeasure":"percentage of participants"}